TABLE 2.
Recent researches of CRISPR pooled library screening in pancreatic cancer.
Hit genes | Effect | Cell line | Library | Gene/sgRNA number | Selection condition | References |
PSMA6 | apoptosis↑, spheroid formation↓ | PANC-1 | Human sgRNA library Brunello (addgene No. 73178) | 19114/76441 | 100 nM gemcitabine for 6 days | Bakke et al., 2019 |
Wnt pathway genes, FZD5 | Proliferation↓ | HPAF-II, AsPC-1, PaTu8988S | Toronto KnockOut (TKO) CRISPR Library (addgene No. 1000000069) | 17232/91320 | different time point (Day 15, 27, 31, 35) | Steinhart et al., 2017 |
CIC, ATXN1L | sensitivity to trametinib↓ | PATU8902 | GeCKOv2 library (addgene No. 1000000049) | 19050/123411 | 100 nM trametinib for 14 days | Wang et al., 2017 |
PATU8988T | Avana library Doench et al., 2016 | 18675/110257 | 10 nM trametinib for 14 days | |||
CENPE, RRM1 | sensitivity to trametinib↑ | PDX366 | Nuclear proteins gRNA sub-pool library (addgene No. 51047) | 7114/73151 | MEK and CENPE inhibitor treatment in 6–8-week-old mail athymic nude mice | Szlachta et al., 2018 |
DCK, DCTPP1 | sensitivity to NUC-1031, gemcitabine↓ | Mia PaCa-2, A2780 | GeCKOv2 library (addgene No. 1000000049) | 19050/123411 | 15 nM gemcitabine or 65 nM NUC-1031 for 14 days or 21 days | Sarr et al., 2019 |
↑, up-regulation; and ↓, down-regulation.